Position
Chief Development Officer
Company
Oculis Holding AG
LausanneBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Dr. Sharon Klier, an executive leader with extensive experience in clinical development, has been appointed as the chief development officer (CDO) at Oculis Holding. In her new role, she will provide strategic leadership across the clinical development and operations of Oculis’ ophthalmology pipeline.
Quick answer
Oculis Holding Appoints Dr. Sharon Klier as Chief Development Officer (August 15, 2024). Oculis Holding AG is based in Lausanne, Vaud, Switzerland.
- Who is the new Chief Development Officer at Oculis Holding AG?
- Oculis Holding AG named Sharon Klier Chief Development Officer, announced August 15, 2024.
- What did Oculis Holding AG announce on August 15, 2024?
- Dr. Sharon Klier, an executive leader with extensive experience in clinical development, has been appointed as the chief development officer (CDO) at Oculis Holding. In her new role, she will provide strategic leadership across the clinical development and operations of Oculis’ ophthalmology pipeline.
- What does Oculis Holding AG do?
- Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care.
- Where is Oculis Holding AG based?
- Oculis Holding AG is based in Lausanne, Vaud, Switzerland.
- Which similar companies made leadership changes around the same time?
- Pfizer (August 13, 2024), Pathalys Pharma (August 13, 2024), Fulcrum Therapeutics (August 19, 2024) and Intra-Cellular Therapies (August 8, 2024) also announced leadership changes within 45 days of Oculis Holding AG.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pfizer Appoints Berta Rodriguez-Hervas as Chief AI and Analytics Officer (August 13, 2024)
- Pathalys Pharma Appoints Bastian Dehmel, M.D. as Chief Medical Officer (August 13, 2024)
- Fulcrum Therapeutics Appoints Isabel Kalofonos as Chief Commercial Officer and Heather Faulds as Chief Regulatory Affairs & Quality Assurance Officer (August 19, 2024)
- Intra-Cellular Therapies Appoints Sanjeev Narula as Executive Vice President, Chief Financial Officer (August 8, 2024)
- Belite Bio, Inc Appoints Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer (September 1, 2024)
- Forward Therapeutics Appoints Ulrich Thienel, M.D., Ph.D. as Chief Medical Officer (September 3, 2024)
Who to call at Oculis Holding AG, and when
A new leader at Oculis Holding AG brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Oculis Holding AG raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oculis Holding AG, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oculis Holding AG. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oculis Holding AG changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Oculis Holding AG changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.